-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Ελλάδα
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Our Latest Whitepapers
Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreBlogs, Case Studies & Podcasts
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
IQVIA APAC Insight
"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue
Featured Event
"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreCareer Opportunities
Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search Jobs
White Paper
Value-Based Market Access Symposium Summary Report
Feb 09, 2023
On 27 June 2022, APACMed held the inaugural Value-Based Market Access Symposium. The Symposium leveraged on technical expertise and real-world operating experience from government affairs and market access industry professionals across 15 APAC markets and 40 companies operating in the medical devices and diagnostics sector. IQVIA being a knowledge partner, developed the report which summarizes the insights shared to facilitate innovative, value-based market access, including in pricing, procurement, and reimbursement.
The Value-Based Health Care system (VBHC) is a framework for restructuring health care systems with the overarching goal of maximizing value for patients, where value is defined as health outcomes per unit of cost. The VBHC system can not only lower health care costs with better outcomes in patients, but also make health care by providers more efficient and targeted, thereby enhancing patient satisfaction. With VBHC systems in place, payers will have evidence based metrics for cost control and risk reduction, while industries will be able to align their prices catered more towards patient outcomes. All these factors will in turn benefit society with subsequent reduction in health care spending and prospects of a better overall health scenario. MedTech can significantly contribute across the care continuum that spans prevention, screening, treatment, recovery, and sustainability. Areas of contribution involve device innovation, data analytics, telehealth solutions, and partnership with providers, health assessment technology bodies and payers. The central theme, however, remains universal evidence-based improvement in patient outcomes.
WEBINAR
Value-Based Market Access Symposium 2022
The inaugural APACMed Value-Based Market Access (VBMA) Symposium will revolve around the theme “The Evolving Health Technology Assessment Landscape for Medical Devices and Diagnostics”.